As a biopharmaceutical and basic research services provider, Creative Biolabs focuses on the development of novel immunotherapies based on ground breaking chimeric antigen receptor (CAR) research and gene therapies in areas of unmet need. We offer comprehensive immune cell products (e.g. including PBMC, T cells, B cells, NK cells, DCs, and stem cells) to facilitate your projects. If you don't find the answers you are looking for, contact one of our scientists for additional assistance.